Intriguing location of myeloperoxidase in the prostate: A preliminary immunohistochemical study

Prostate

Volumn 72, Issue 5, 2012, Pages 507-513

  Roumeguér, Th ^a,b   Delree, P ^c   Van Antwerpen, P ^d   Rorive, S ^b   Vanhamme, L ^d   De Ryhove, L De La Kethulle ^e   Serteyn, D ^f   Wespes, E ^a   Vanhaerverbeek, M ^a   Boudjeltia, K Zouaoui ^a  

^a Centre Hospitalier Universitaire de Charleroi   (Belgium)

^b ERASME HOSPITAL   (Belgium)

^c the Institute of Pathology and Genetic   (Belgium)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^e Mons University   (Belgium)

^f UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

inflammation; myeloperoxidase; oxidative stress; prostate cancer; prostate hypertrophy

Indexed keywords

MYELOPEROXIDASE;

ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; RADICAL RETROPUBIC PROSTATECTOMY; TRANSURETHRAL RESECTION;

ADENOMA; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PEROXIDASE; PROSTATE; PROSTATECTOMY; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 84857501705     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21452     Document Type: Article

References (22)

1. Alcaraz A, Hammerer P, Tubaro A, Schröder F, Castro R,. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol 2009; 55: 864-875.
2. Schottenfeld D, Beebe-Dimmer J,. Chronic inflammation: A common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin 2006; 56 (2): 69-83.
3. De Marzo AM, Marchi VL, Epstein JI, Nelson WG,. Proliferative inflammatory atrophy of the prostate. Am J Pathol 1999; 155: 1985-1992.
4. Ludwig M, Vidal A, Diemer T, Pabst W, Failing K, Weidner W,. Chronic prostatitis/chronic pelvic pain syndrome: Seminal markers of inflammation. World J Urol 2003; 21: 82-85.
5. Klebanoff SJ,. Myeloperoxidase: Friend and foe. J Leukoc Biol 2005; 77: 598-625.
6. Boudjeltia KZ, Legssyer I, Van Antwerpen P, Kisoka RL, Babar S, Moguilevsky N, Delree P, Ducobu J, Remacle C, Vanhaeverbeek M, Brohee D,. Triggering of inflammatory response by myeloperoxidase-oxidized LDL. Biochem Cell Biol 2006; 84 (5): 805-812.
7. Kramer G, Mitteregger D, Marberger M,. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 2007; 51: 1202-1216.
8. Nickel JC, Roehrborn CG, O'Leary MP, Bostwick DG, Somerville MC, Rittmaster RS,. The relationship between prostate inflammation and lower urinary tract symptoms: Examination of baseline data from the REDUCE trial. Eur Urol 2008; 54: 1379-1384.
9. Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A,. Gentile V inflammation and chronic prostatic diseases: Evidence for a link? Eur Urol 2007; 52: 964-972.
10. MacLennan GT, Eisenberg R, Fleshman RL, Taylor JM, Fu P, Resnick MI, Gupta S,. The influence of chronic inflammation in prostatic carcinogenesis: A 5-year follow-up study. J Urol 2006; 176: 1012-1016.
11. Prakash K, Pirozzi G, Elashoff M, Munger W, Waga I, Dhir R, Kakehi Y, Getzenberg RH,. Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays. Proc Natl Acad Sci USA 2002; 99: 7598-7603.
12. Güngor N, Godschalk R, Pachen D, Van Schooten FJ, Knaapen AM,. Activated neutrophils inhibit nucleotide excision repair in human pulmonary epithelial cells: Role of myeloperoxidase. FASEB J 2007; 21: 2236-2359.
13. Schabath MB, Spitz MR, Zhang X, Delclos GL, Wu X,. Genetic variants of myeloperoxidase and lung cancer risk. Carcinogenesis 2000; 21: 1163-1166.
14. Ambrosone C, Ahn J, Singh K, Rezaishiraz H, Furberg H, Sweeney C, Coles B, Trovato A,. Polymorphisms in genes related to oxidative stress (MPO, MnSOD, CAT) and survival after treatment for breast cancer. Cancer Res 2005; 65 (3): 1105-1111.
15. Hung RJ, Boffetta P, Brennan P, Malaveille C, Gelatti U, Placidi D, Carta A, Hautefeuille A, Porru S,. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis 2004; 25 (6): 973-978.
16. Palapattu GS, Sutcliffe S, Bastain PJ, Platz EA,. Prostate carcinogenesis and inflammation: Emerging insights. Carcinogenesis 2004; 26: 1170-1181.
17. Sugar LM,. Inflammation and prostate cancer. Can J Urol 2006; 13 (Suppl 1): 46-47.
18. Van Antwerpen P, Slomianny MC, Boudjeltia KZ, Delporte C, Faid V, Calay D, Rousseau A, Moguilevsky N, Raes M, Vanhamme L, Furtmüller PG, Obinger C, Vanhaeverbeek M, NÃ̈ve J, Michalski JC,. Glycosylation pattern of mature dimeric leukocyte and recombinant monomeric myeloperoxidase: Glycosylation is required for optimal enzymatic activity. J Biol Chem 2010; 285: 16351-16359.
19. Henderson JP, Byun J, Heinecke JW,. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA. J Biol Chem 1999; 274 (47): 33440-33448.
20. Jiang Q, Blount BC, Ames BN,. 5-Chlorouracil, a marker of DNA damage from hypochlorous acid during inflammation. J Biol Chem 2003; 278 (35): 32834-32840.
21. Iwamoto H, Kobayashi T, Hasegawa E, Morita Y,. Reaction of human myeloperoxidase with hydrogen peroxide and its true catalase activity. J Biochem 1987; 101 (6): 1407-1412.
22. Kettle AJ, Winterbourn CC,. A kinetic analysis of the catalase activity of myeloperoxidase. Biochemistry 2001; 40 (34): 10204-10212.